← 返回

区域特异性 CD16(+) 中性粒细胞通过抑制 NK 细胞促进结直肠癌进展

英文原题:Region-Specific CD16(+) Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer Cells.

查看英文原题

Region-Specific CD16(+) Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer Cells.

PubMed 2024/05/24(内容时间) Adv Sci (Weinh) Q1 · IF 14.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

结肠是免疫系统最大的组成部分,其中先天免疫细胞暴露于环境中的抗原。然而,在结直肠癌(CRC)中,先天免疫系统被激发的机制尚不明确。本研究通过成像质谱流式(IMC)、免疫荧光和流式细胞术,鉴定出一群特异性积聚在CRC肿瘤组织中的CD16+中性粒细胞,其通过干扰自然杀伤(NK)细胞表现出促肿瘤活性。研究发现,这些CD16+中性粒细胞由于CD16/TAK1/NF-κB轴的激活而具有异常的胆固醇蓄积,该轴上调了包括CD36和LRP1在内的胆固醇摄取清道夫受体。因此,这些区域特异性的CD16+中性粒细胞不仅竞争性抑制NK细胞的胆固醇摄取,从而中断NK细胞脂筏形成并阻断其抗肿瘤信号,还释放中性粒细胞胞外诱捕网(NETs)诱导NK细胞死亡。此外,CD16敲除逆转了中性粒细胞的促肿瘤活性并恢复了NK细胞毒性。总之,这些发现表明CRC区域特异性CD16+中性粒细胞可作为CRC的诊断标志物和潜在治疗靶点。

展开英文摘要原文

The colon is the largest compartment of the immune system, with innate immune cells exposed to antigens in the environment.

However, the mechanisms by which the innate immune system is instigated are poorly defined in colorectal cancer (CRC).

Here, a population of CD16 + neutrophils that specifically accumulate in CRC tumor tissues by imaging mass cytometry (IMC), immune fluorescence, and flow cytometry, which demonstrated pro-tumor activity by disturbing natural killer (NK) cells are identified. It is found that these CD16 + neutrophils possess abnormal cholesterol accumulation due to activation of the CD16/TAK1/NF-κB axis, which upregulates scavenger receptors for cholesterol intake including CD36 and LRP1.

Consequently, these region-specific CD16 + neutrophils not only competitively inhibit cholesterol intake of NK cells, which interrupts NK lipid raft formation and blocks their antitumor signaling but also release neutrophil extracellular traps (NETs) to induce the death of NK cells.

Furthermore, CD16-knockout reverses the pro-tumor activity of neutrophils and restored NK cell cytotoxicity. Collectively, the findings suggest that CRC region-specific CD16 + neutrophils can be a diagnostic marker and potential therapeutic target for CRC.

论文信息

作者
Zhang Y、Wang Z、Lu Y、Sanchez DJ、Li J、Wang L、Meng X、Chen J
第一作者单位
State Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.China
通讯作者单位
State Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.China
文献类型
非美国政府资助研究
期刊
Advanced science (Weinheim, Baden-Wurttemberg, Germany)2024 Aug
原文标识
PubMed 38790136 · DOI 10.1002/advs.202403414